{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:06:57Z","timestamp":1759410417263},"reference-count":30,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.vaccine.2008.03.064","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T21:35:23Z","timestamp":1208468123000},"page":"5216-5222","source":"Crossref","is-referenced-by-count":37,"title":["Potentiation of an anthrax DNA vaccine with electroporation"],"prefix":"10.1016","volume":"26","author":[{"given":"A.","family":"Luxembourg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hannaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ellefsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Tellez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"53","key":"10.1016\/j.vaccine.2008.03.064_bib1","first-page":"13109","article-title":"Office of the Assistant Secretary for Preparedness and Response; HHS Public Health Emergency Medical Countermeasures Enterprise Strategy for chemical, biological, radiological and nuclear threats","volume":"72","author":"Parker","year":"2007","journal-title":"Fed Register"},{"issue":"10","key":"10.1016\/j.vaccine.2008.03.064_bib2","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1517\/14712598.4.10.1661","article-title":"DNA vaccines against anthrax","volume":"4","author":"Galloway","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"10.1016\/j.vaccine.2008.03.064_bib3","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/14712598.7.11.1647","article-title":"Electroporation-based DNA immunisation: translation to the clinic","volume":"7","author":"Luxembourg","year":"2007","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.064_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molmed.2006.03.007","article-title":"Gene-based vaccines: recent technical and clinical advances","volume":"12","author":"Ulmer","year":"2006","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.064_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/71889","article-title":"Synthetic DNA delivery systems","volume":"18","author":"Luo","year":"2000","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.03.064_bib6","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.164.9.4635","article-title":"Increased DNA vaccine delivery and immunogenicity by electroporation in vivo","volume":"164","author":"Widera","year":"2000","journal-title":"J Immunol"},{"issue":"21","key":"10.1016\/j.vaccine.2008.03.064_bib7","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2005.08.014","article-title":"Enhancement of immune responses to an HBV DNA vaccine by electroporation","volume":"24","author":"Luxembourg","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.03.064_bib8","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.4049\/jimmunol.177.10.7462","article-title":"Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates","volume":"177","author":"Capone","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.03.064_bib9","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/JVI.00055-07","article-title":"Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques","volume":"81","author":"Luckay","year":"2007","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.064_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mib.2003.12.001","article-title":"The roles of anthrax toxin in pathogenesis","volume":"7","author":"Moayeri","year":"2004","journal-title":"Curr Opin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.064_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00189414","article-title":"Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"177","author":"Turnbull","year":"1988","journal-title":"Med Microbiol Immunol (Berl)"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.064_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","article-title":"In vitro correlate of immunity in an animal model of inhalational anthrax","volume":"87","author":"Pitt","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"32","key":"10.1016\/j.vaccine.2008.03.064_bib13","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"issue":"23-24","key":"10.1016\/j.vaccine.2008.03.064_bib14","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.064_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.064_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.03.064_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00063030-200519040-00003","article-title":"Anthrax vaccines: a development update","volume":"19","author":"Little","year":"2005","journal-title":"BioDrugs"},{"issue":"7","key":"10.1016\/j.vaccine.2008.03.064_bib18","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.064_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(86)90268-1","article-title":"Antibody avidity determination by ELISA using thiocyanate elution","volume":"86","author":"Pullen","year":"1986","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.064_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0022-1759(95)00186-4","article-title":"The assessment of antibody affinity distribution by thiocyanate elution: a simple dose\u2013response approach","volume":"187","author":"Ferreira","year":"1995","journal-title":"J Immunol Methods"},{"issue":"9","key":"10.1016\/j.vaccine.2008.03.064_bib21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/jgm.941","article-title":"DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity","volume":"8","author":"Kim","year":"2006","journal-title":"J Gene Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.064_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2672.1999.00901.x","article-title":"Presentation of protective antigen to the mouse immune system: immune sequelae","volume":"87","author":"Williamson","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.03.064_bib23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"issue":"Pt. 3","key":"10.1016\/j.vaccine.2008.03.064_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1099\/13500872-142-3-707","article-title":"Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies","volume":"142","author":"Little","year":"1996","journal-title":"Microbiology"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.064_bib25","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.4049\/jimmunol.178.5.2646","article-title":"IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis","volume":"178","author":"Glomski","year":"2007","journal-title":"J Immunol"},{"issue":"7019","key":"10.1016\/j.vaccine.2008.03.064_bib26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nature03087","article-title":"Public health vaccination policies for containing an anthrax outbreak","volume":"432","author":"Brookmeyer","year":"2004","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2008.03.064_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-142-8-200504190-00008","article-title":"Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax","volume":"142","author":"Fowler","year":"2005","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.vaccine.2008.03.064_bib28","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1128\/JVI.02536-06","article-title":"Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy","volume":"81","author":"Law","year":"2007","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2008.03.064_bib29","doi-asserted-by":"crossref","first-page":"11598","DOI":"10.1128\/JVI.74.24.11598-11607.2000","article-title":"Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer","volume":"74","author":"Zucchelli","year":"2000","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2008.03.064_bib30","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.vaccine.2003.11.073","article-title":"Enhancement of DNA vaccine potency in rhesus macaques by electroporation","volume":"22","author":"Otten","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0800354X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0800354X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T13:31:26Z","timestamp":1588599086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0800354X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":30,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0264410X0800354X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}